Author

Anandita Mathur

University College London

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Assay:flow cytometry· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Brian Ritchie DavidsoniD· 2 shared Ginevra Pistocchi· 2 shared Laura J. PallettiD· 2 shared Mala K. MainiiD· 2 shared Alberto QuagliaiD· 1 shared Alexandrine CarminatiiD· 1 shared Andrew Rennie HalliD· 1 shared Avinash GuptaiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Brian Ritchie DavidsonORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Human hepatic stellate cells orchestrate the accumulation and function of CD103+ tissue-resident CD8+ T-cells in liver fibrosis

George E. Finney, Daniel Brown Romero, Ginevra Pistocchi, Bethany H. James, Scott P Davies, Stephanie Kucykowicz, Anandita Mathur, Keshav Rao, Kexin Kong, Jacky Tam, Juliet Luft, Niamah A. Nishan, Giulia Lupo, Walid Al‐Akkad, Maria Castanho Martins, , Laura J. Pallett

bioRxiv · Dec 2, 2025 · PreprintImmunology

Splenic granulopoiesis and S100A9 drive resistance to checkpoint inhibitors conferred by liver metastases

Rebecca J. Lee, Steven Hooper, Laura J. Pallett, Mariana O. Diniz, Tate Mckinnon-Snell, Zoe Ramsden, Nicolas Rabas, Stefan Boeing, Oliver John Kennedy, Charlotte Buttercase, Gloryanne Aidoo-Micah, Gareth J. Price, Sarah C. Macfarlane, Sasha Bailey, Jessica E. Davies, , Erik A. Sahai

This study shows liver metastases reduce checkpoint inhibitor efficacy by increasing splenic granulopoiesis and S100A9hi neutrophils, which suppress T-cell responses, and demonstrates that targeting S100A9 restores efficacy.

bioRxiv · Sep 30, 2025 · PreprintImmunology